FF6-24626-49721
3 vaccinations
10 coded responses
23 check-ins
10 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 754 / TX
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Registered in v-safe
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal, Neck pain, Paraesthesia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: brain fog", neck pain, finger tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-23
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-25
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia, Rhinorrhoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Rhinorrhea, paresthesia (vaccinated arm/fingers)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: RhinorrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-18
Report sent to call center — day 7, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-26
Survey response — day 14, dose 2MedDRA: Dyspnoea, Flushing, Hyperhidrosis, Tachycardia — Feeling: FairFree text: Tachycardia, intermittent shortness of breath, intermittent sweating/flushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-08
-
2021-02-24
Survey response — day 42, dose 2MedDRA: Dizziness, Fatigue, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme fatigue, dizziness, tachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Disturbance in attention, Fatigue, Memory impairment — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMemory problems Focus problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Headache, Malaise, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, sore throat, low grade fever, headache, malaiseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-22
- 2021-07-27
-
2021-11-10
Dose 3 — Moderna
-
2022-01-11
Survey response — 12 months, dose 2MedDRA: Alopecia, Exercise tolerance decreased, Fatigue, Heart rate increased, Hypertension, Insomnia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hair loss, high blood pressure and elevated heart rate, insomnia, fatigue, activity intoleranceMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-12
- 2022-01-17
-
2022-02-09
Survey response — 3 months, dose 3MedDRA: Alopecia, Blood pressure increased, Fatigue, Loss of personal independence in daily activities, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hair loss, fatigue, tachycardia, activity intolerance, elevated blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-11
- 2022-02-16
-
2022-11-13
Survey response — 12 months, dose 3MedDRA: Brain fog, Fatigue, Loss of personal independence in daily activities — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Extreme fatigue, activity intolerance, brain fogMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Moderna | No |
Call center
9 call center cases
3 unsuccessful · 6 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): brain fog", neck pain, finger tingling
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Rhinorrhea, paresthesia (vaccinated arm/fingers)
Systemic reaction (other): Rhinorrhea
Release 2 — day 14, dose 2
Symptoms: Tachycardia, intermittent shortness of breath, intermittent sweating/flushing
Release 4 — day 42, dose 2
Symptoms: Extreme fatigue, dizziness, tachycardia
Release 7 — 3 months, dose 2
Symptoms: FatigueMemory problems Focus problems
Release 9 — 6 months, dose 2
Symptoms: Congestion, sore throat, low grade fever, headache, malaise
Release 10 — 12 months, dose 2
Symptoms: Hair loss, high blood pressure and elevated heart rate, insomnia, fatigue, activity intolerance
Release 11 — 3 months, dose 3
Symptoms: Hair loss, fatigue, tachycardia, activity intolerance, elevated blood pressure
Release 12 — 12 months, dose 3
Symptoms: Extreme fatigue, activity intolerance, brain fog
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Flushing | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hyperhidrosis | ✓ | ✓ | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Memory impairment | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release